Actinium Pharmaceuticals, Inc. (ATNM)
NYSEAMERICAN: ATNM · Real-Time Price · USD
1.100
+0.020 (1.85%)
Oct 9, 2026, 4:00 PM EDT - Market closed
Actinium Pharmaceuticals Stock Forecast
Stock Price Forecast
According to 5 analysts polled by S&P Global, Actinium Pharmaceuticals stock has a consensus rating of "Buy" and an average price target of $3.60. The average 1-year stock price forecast is 227.27% higher than the current stock price, while the lowest is $2.00 (+81.82%) and the highest is $5.00 (+354.55%).
Price Target: $3.60 (+227.27%)
Analyst Consensus: Buy
Price Target
ChartAnalyst Ratings
The average analyst rating for Actinium Pharmaceuticals stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Mar '26 | Apr '26 | May '26 | Jun '26 | Aug '26 | Sep '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 3 | 3 | 3 | 2 | 2 | 2 |
| Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Hold | 1 | 1 | 1 | 1 | 1 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 5 | 5 | 5 | 4 | 4 | 4 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| H.C. Wainwright | H.C. Wainwright | Buy Reiterates $4 | Buy | Reiterates | $4 | +263.64% | Oct 5, 2026 |
| JonesTrading | JonesTrading | Buy Reiterates $9 → $3 | Buy | Reiterates | $9 → $3 | +172.73% | Aug 14, 2026 |
| Maxim Group | Maxim Group | Buy Maintains $5 | Buy | Maintains | $5 | +354.55% | Apr 8, 2026 |
Financial Forecast
Revenue This Year
17.50M
from 90.00K
Increased by 19,344.44%
Revenue Next Year
n/a
from 17.50M
Decreased by -100.00%
EPS This Year
0.14
from -1.09
EPS Next Year
-0.53
from 0.14
EPS and Forward PE are based on non-GAAP adjusted numbers.